CASE SERIES OF PATIENTS WITH SYSTEMIC SCLEROSIS AND POSITIVE ANTI-CENTROMERE ANTIBODIES: CLASSIFICATION AND CLINICAL MANIFESTATIONS

被引：0

作者：

Maicas, L. Salvador ^{[1
]}

Gil, J. J. Fragio ^{[1
]}

Gonzalez-Mazario, R. ^{[1
]}

Calabuig, P. Martinez ^{[1
]}

Martinez, M. L. Sanmartin ^{[1
]}

Rivera, A. Sierra ^{[2
]}

Cid, A. Rueda ^{[1
]}

Garrido, J. J. Lerma ^{[1
]}

Almela, C. Molina ^{[1
]}

Timoneda, P. T. Timoneda ^{[2
]}

Fernandez, C. Campos ^{[1
]}

机构：

[1] Hosp Gen Univ, Rheumatol, Valencia, Spain

[2] Hosp Gen Univ, Clin Anal, Valencia, Spain

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷

关键词：

Autoantibodies; Comorbidities; Biomarkers;

D O I：

10.1136/annrheumdis-2024-eular.6044

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB1236

引用

页数：2

共 50 条

[21] Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?
Benyamine, Audrey
Bertin, Daniel
Heim, Xavier
Granel, Brigitte
Bardin, Nathalie
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 44 : E42 - E44
[22] Primary Biliary Cholangitis Unveiled by Positive Anti-centromere Antibodies
Bolano, Luis A. Penaranda
Mederos-Rocha, Natasha
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1819 - S1819
[23] Ability of anti-centromere and anti-topoisomerase antibodies to distinguish subsets of skin involvement in systemic sclerosis.
Hudson, Marie
Taillefer, Suzanne
Steele, Russell
Fritzler, Marvin
Baron, Murray
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S482 - S482
[24] Clinical features of anti-chromo antibodies associated with anti-centromere antibodies
Iwai, T
Muro, Y
Sugimoto, K
Matsumoto, Y
Ohashi, M
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (02): : 285 - 290
[25] MYOCARDIAL INVOLVEMENT CHARACTERIZES EARLY SYSTEMIC SCLEROSIS WITH ANTI-SCL70 ANTIBODIES AND LONGSTANDING DISEASE WITH ANTI-CENTROMERE ANTIBODIES
De Santis, M.
Tonutti, A.
Motta, F.
Rodolfi, S.
Monti, L.
Francone, M.
Selmi, C.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 988 - 989
[26] The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature
Hoekstra, E. M.
Liem, S. I. E.
Boonstra, M.
Fehres, C. M.
Schoones, J. W.
Huizinga, T. W. J.
de Vries-Bouwstra, J. K.
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 72
[27] Clinical manifestations of a series of patients with systemic sclerosis
Rodriguez Echegoyen, Dalgis Ruth
Lopez Mantecon, Ana Marta
Pozo Abreu, Silvia Maria
Mederos Castellanos, Ailyn
Martinez Larrarte, Jose Pedro
REVISTA CUBANA DE REUMATOLOGIA, 2023, 25 (01):
[28] Severe myositis and perimyocarditis in anti-centromere positive systemic sclerosis complicated by thrombotic microangiopathy and renal insufficiency
Matthias, Gasser
Rucsandra, Dobrota
Christine, Schneider
Corina, Ebnother
Jan, Triebel
Britta, Maurer
SWISS MEDICAL WEEKLY, 2019, : 11S - 11S
[29] ANTINUCLEAR ANTIBODIES IN PATIENTS WITH RAYNAUDS-PHENOMENON - CLINICAL-SIGNIFICANCE OF ANTI-CENTROMERE ANTIBODIES
KALLENBERG, CGM
PASTOOR, GW
WOUDA, AA
THE, TH
ANNALS OF THE RHEUMATIC DISEASES, 1982, 41 (04) : 382 - 387
[30] Six cases positive for anti-centromere antibodies with ulcer and gangrene in the extremities
Takahashi, M
Okada, J
Kondo, H
BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (08): : 889 - 893

← 1 2 3 4 5 →